Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$0.32 - $0.52 $886,879 - $1.44 Million
-2,771,497 Reduced 72.08%
1,073,491 $397,000
Q3 2022

Nov 14, 2022

SELL
$0.43 - $1.56 $1.81 Million - $6.56 Million
-4,206,870 Reduced 52.25%
3,844,988 $1.65 Million
Q2 2022

Aug 15, 2022

BUY
$0.7 - $1.4 $144,292 - $288,584
206,132 Added 2.63%
8,051,858 $6.28 Million
Q1 2022

May 16, 2022

BUY
$0.63 - $1.59 $4.4 Million - $11.1 Million
6,983,089 Added 809.5%
7,845,726 $10.1 Million
Q4 2021

Feb 14, 2022

BUY
$1.27 - $2.42 $774,715 - $1.48 Million
610,012 Added 241.47%
862,637 $1.1 Million
Q3 2021

Nov 15, 2021

SELL
$2.15 - $3.82 $689,661 - $1.23 Million
-320,773 Reduced 55.94%
252,625 $550,000
Q2 2021

Aug 16, 2021

BUY
$2.89 - $4.45 $143,225 - $220,537
49,559 Added 9.46%
573,398 $2.15 Million
Q1 2021

May 17, 2021

SELL
$2.9 - $4.09 $1.76 Million - $2.49 Million
-608,001 Reduced 53.72%
523,839 $1.71 Million
Q4 2020

Feb 16, 2021

BUY
$3.38 - $5.14 $645,769 - $982,027
191,056 Added 20.31%
1,131,840 $3.86 Million
Q3 2020

Nov 16, 2020

SELL
$2.99 - $4.9 $1.85 Million - $3.02 Million
-617,291 Reduced 39.62%
940,784 $3.84 Million
Q2 2020

Aug 14, 2020

BUY
$2.11 - $3.38 $1.87 Million - $3 Million
887,469 Added 132.34%
1,558,075 $5.27 Million
Q1 2020

May 15, 2020

BUY
$1.83 - $3.45 $811,235 - $1.53 Million
443,298 Added 195.02%
670,606 $1.56 Million
Q4 2019

Feb 14, 2020

BUY
$3.5 - $10.35 $795,578 - $2.35 Million
227,308 New
227,308 $827,000
Q4 2018

Feb 14, 2019

SELL
$6.39 - $16.99 $258,322 - $686,837
-40,426 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$16.52 - $24.82 $6.4 Million - $9.62 Million
-387,421 Reduced 90.55%
40,426 $679,000
Q2 2018

Aug 14, 2018

SELL
$14.31 - $21.75 $13.5 Million - $20.5 Million
-942,770 Reduced 68.78%
427,847 $8.97 Million
Q1 2018

May 15, 2018

SELL
$16.09 - $23.07 $9.94 Million - $14.3 Million
-617,860 Reduced 31.07%
1,370,617 $22.1 Million
Q4 2017

Feb 14, 2018

SELL
$13.36 - $20.73 $11.5 Million - $17.8 Million
-860,691 Reduced 30.21%
1,988,477 $37.7 Million
Q3 2017

Nov 14, 2017

BUY
$8.75 - $14.07 $24.9 Million - $40.1 Million
2,849,168
2,849,168 $40.1 Million

Others Institutions Holding SPPI

# of Institutions
1
Shares Held
115K
Call Options Held
0
Put Options Held
0

About SPECTRUM PHARMACEUTICALS INC


  • Ticker SPPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,164,000
  • Description
  • Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...
More about SPPI
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.